Currently out of the existing stock ratings of Caroline Palomeque, 9 are a BUY (81.82%), 2 are a HOLD (18.18%).

Caroline Palomeque

Work Performance Price Targets & Ratings Chart

Analyst Caroline Palomeque, carries an average stock price target met ratio of 28.57% that have a potential upside of 50.35% achieved within 593 days. Previously, Caroline Palomeque worked at MAXIM GROUP.

Caroline Palomeque’s has documented 21 price targets and ratings displayed on 7 stocks. The coverage was on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on DARE, Dare Bioscience at 04-Sep-2025.

Wall Street Analyst Caroline Palomeque

Analyst best performing recommendations are on AVXL (ANAVEX LIFE SCIENCES CORP).
The best stock recommendation documented was for AVXL (ANAVEX LIFE SCIENCES CORP) at 5/16/2018. The price target of $7 was fulfilled within 904 days with a profit of $4.56 (186.89%) receiving and performance score of 2.07.

Average potential price target upside

AVXL Anavex Life Sciences Corp DARE Dare Bioscience ASND Ascendis Pharma AS CE Celanese CERC Cerecor DNLI Denali Therapeutics RGNX Regenxbio

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Nov-2015

$24

$21.38 (816.03%)

$24

3 months 26 days ago
(31-Mar-2026)

5/13 (38.46%)

$20.93 (681.76%)

1510

Buy Since 16-Mar-2020

5 months 17 days ago
(10-Feb-2026)

3/17 (17.65%)

$32.22 (329.45%)

204

Buy Since 29-Jul-2021

$15

9 months 3 days ago
(24-Oct-2025)

0/9 (0%)

$8.18 (119.94%)

Buy Since 24-Sep-2021

$28

$25.05 (849.15%)

$35

3 years 5 months 18 days ago
(09-Feb-2023)

0/4 (0%)

$17.59 (168.97%)

Buy Since 26-Feb-2020

$11

$8.05 (272.88%)

3 years 7 months 21 days ago
(06-Dec-2022)

3/4 (75%)

$2.62 (31.26%)

139

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Caroline Palomeque?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?